Ferring Receives U.S. FDA Approval for REBYOTA™ – A Novel First-in-Class Microbiota-Based Live Biotherapeutic
Ferring Pharmaceuticals today announced the U.S. Food and Drug Administration (FDA) approved REBYOTA™ (fecal microbiota, live-jslm).
A New Approach to Spotting Tumors: Look for Their Microbes – New York Times
New research is revealing that cancer is rife with bacteria and fungi — a rich ecosystem that scientists call the tumor microbiome.
Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions
Cancer-microbe associations have been explored for centuries, but cancer-associated fungi have rarely been examined.
PubMed – A communal catalogue reveals Earth’s multiscale microbial diversity
Our growing awareness of the microbial world’s importance and diversity contrasts starkly with our limited understanding of its fundamental structure.
American Society for Microbiology – COVID-19 and the Gut Microbiome: More than a Gut Feeling
Due to its fundamental role in the induction, training, and function of the immune system, it is critical to include characterizations of the gut microbiome in clinical trials and studies that aim to broaden our understanding of coronavirus disease 2019 (COVID-19).
Nature Communications – Rationally design bacterial consortia to treat chronic immune medicated colitis and restore intestinal homeoestasis
Environmental factors, mucosal permeability and defective immunoregulation drive over- active immunity to a subset of resident intestinal bacteria that mediate multiple inflammatory conditions.
National Library of Medicine – The Microbiome As A Source of New Enterprise and Job Creation
The Microbiome as a source of new enterprises and job creation: Considering clinical faecal and synthetic microbiome transplants and therapeutic regulation.